Comments
Loading...

Cardiff Oncology

CRDFNASDAQ
$2.55
-0.05-1.92%
Last update: 10:16 AM
15 minutes delayed

Cardiff Oncology (NASDAQ:CRDF) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Get Alert
No data available to display

FAQ

Q

What is the most recent guidance for Cardiff Oncology (CRDF)?

A

There have been no specific sales or earnings guidance reported for Cardiff Oncology in recent months.

Browse guidance and forecast on all stocks.

People Also Watch